三达膜(688101) - 2022 Q4 - 年度财报

Financial Performance - The net profit attributable to shareholders for 2022 was CNY 217,902,483.86, with undistributed profits amounting to CNY 1,584,999,370.12[5]. - The company achieved operating revenue of CNY 1,259,160,685.98 in 2022, representing a year-on-year increase of 9.42%[24]. - Net profit attributable to shareholders was CNY 217,902,483.86, a decrease of 11.82% compared to the previous year[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 186,487,630.01, down 14.63% year-on-year[24]. - The net cash flow from operating activities increased by 11.85% to CNY 247,329,288.25, mainly due to increased cash received from sales of goods and services[24]. - The company's total assets at the end of 2022 were CNY 5,298,919,980.32, reflecting a 9.15% increase from the previous year[24]. - The weighted average return on net assets decreased to 6.24%, down 1.16 percentage points from the previous year[25]. - Research and development expenses accounted for 4.83% of operating revenue, an increase of 0.29 percentage points compared to the previous year[25]. Corporate Governance - The board of directors and management have confirmed the accuracy and completeness of the financial report, with no significant omissions or misleading statements[4]. - The report emphasizes the importance of corporate governance and the presence of all board members during the meeting[5]. - The company has established a governance structure that complies with relevant laws and regulations, ensuring effective operation and risk management[145]. - The company maintains transparent information disclosure practices, ensuring all investors have equal access to information[148]. - All proposals at the five shareholder meetings held in 2022 were approved without any rejections[154]. - The company held its first extraordinary general meeting on January 17, 2022, to elect members of the board and supervisory committee[152]. - The annual general meeting on May 11, 2022, approved the 2021 annual report and financial statements[152]. - The company has established specialized committees under the board, including the audit committee and the nomination committee, to enhance governance[180]. Research and Development - The company is actively engaged in research and development of graphene membranes, which are anticipated to enhance performance in water treatment applications[15]. - The company has over 20 R&D projects completed during the reporting period, indicating a strong focus on innovation[36]. - The total R&D investment for the year was approximately ¥60.82 million, an increase of 16.47% from the previous year's ¥52.21 million, representing 4.83% of total revenue[75]. - The company applied for a total of 334 patents by December 31, 2022, including 200 invention patents, and received 187 authorized patents, with 184 remaining valid after three expired[72]. - The company has developed advanced inorganic non-metallic membrane materials with independent intellectual property rights, which can replace imported products and offer superior performance[46]. - The company has established a strong market influence and authority in the membrane technology application field, with significant experience in industrial liquid separation and membrane water treatment[87]. Operational Risks and Mitigation - The company has outlined various operational risks and corresponding mitigation strategies in the report[4]. - The report includes a forward-looking statement risk declaration, indicating that future strategies and plans are subject to investment risks[6]. - The company has not engaged in any non-operational fund occupation by controlling shareholders or related parties[7]. - There are no violations of decision-making procedures regarding external guarantees[7]. - The company faces risks from changes in major customers' production expansion needs, which can lead to fluctuations in operational performance[93]. - The company's revenue is closely tied to macroeconomic conditions and environmental policies, making it susceptible to fluctuations in market demand[97]. Sustainability and Environmental Impact - The company is committed to sustainable practices, aiming to reduce the environmental impact of its operations through innovative technologies[14]. - The company emphasizes the importance of ESG, integrating it into its core business operations, viewing it as a cornerstone for sustainable development[200]. - The company is actively pursuing low-carbon goals and aims to establish efficient, clean, and circular green factories[200]. - The company has implemented a management system audit and energy-saving certification to enhance operational efficiency[200]. Market Position and Growth Strategy - The anticipated growth in the municipal and industrial wastewater treatment sectors is expected to drive revenue growth in the coming years[15]. - The company is exploring strategic partnerships and potential acquisitions to bolster its market position and technological capabilities[16]. - The company aims to enhance its market position through continuous innovation and the development of proprietary technologies in the membrane sector[62]. - The company plans to leverage its experience and brand advantage in membrane technology to create a comprehensive membrane industry chain covering materials, components, equipment, software, and applications[139]. - The company will focus on international market expansion, particularly in Southeast Asia, by enhancing its sales team and recruiting talent[143]. Employee and Management Structure - The total number of employees in the parent company and major subsidiaries is 1,159, with 668 in production, 61 in sales, 224 in technology, and 45 in finance[188]. - The company has established a scientific and fair compensation mechanism based on job importance and scarcity, ensuring employee stability and satisfaction[190]. - Total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to 478.48 million[171]. - The company has expanded its leadership team with individuals holding key positions across multiple subsidiaries, enhancing its operational capabilities[169]. Financial Management - The company plans to utilize remaining fundraising for permanent working capital after project completions[105]. - The company has adjusted the implementation content and postponed the Singapore R&D center project to March 2024 due to public health safety controls[103]. - The company has established a strict management system for subsidiaries, ensuring compliance with regulations and timely decision-making[198]. - The company has implemented a remuneration scheme for directors and senior management based on actual operating conditions[171].